Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab Retreatments in Choroidal Neovascularization
NCT00406744Phase 3Terminated
- Sponsor
- Asociación para Evitar la Ceguera en México
- Start
- May 2006
- Primary completion
- May 2006
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of bevacizumab in choroidal neovascularization (CNV), sponsored by Asociación para Evitar la Ceguera en México. Started May 2006; status: terminated.
02
Drugs
bevacizumab
03
Conditions
choroidal neovascularization (CNV)
Beyond the preview
Go deeper on NCT00406744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00406744.